AK109
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AK109, covering 2024-06-24 to 2025-11-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study of AK109 and AK104 in Advanced Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]